Please use this identifier to cite or link to this item:
|Title:||Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals||Authors:||Wens, B.
DE BOEVER, Patrick
|Issue Date:||2013||Publisher:||ELSEVIER IRELAND LTD||Source:||TOXICOLOGY, 303 (1), p. 17-24||Abstract:||Endocrine disrupting chemicals (EDCs) have the potential to interfere with the hormonal system and may negatively influence human health. Microarray analysis was used in this study to investigate differential gene expression in human peripheral blood cells (PBMCs) after in vitro exposure to EDCs. PBMCs, isolated from blood samples of four male and four female healthy individuals, were exposed in vitro for 18 h to either a dioxin-like polychlorinated biphenyl (PCB126, 1 mu M), a non-dioxin-like polychlorinated biphenyl (PCB153, 10 mu M), a brominated flame retardant (BDE47, 10 mu M), a perfluorinated alkyl acid (PFOA, 10 mu M) or bisphenol (BPA, 10 mu M). ANOVA analysis revealed a significant change in the expression of 862 genes as a result of EDC exposure. The gender of the donors did not affect gene expression. Hierarchical cluster analysis created three groups and clustered: (1) PCB126-exposed samples, (2) PCB153 and BDE47, (3) PFOA and BPA. The number of differentially expressed genes varied per compound and ranged from 60 to 192 when using fold change and multiplicity corrected p-value as filtering criteria. Exposure to PCB126 induced the AhR signaling pathway. BDE47 and PCB153 are known to disrupt thyroid metabolism and exposure influenced the expression of the nuclear receptors PPAR gamma and ESR2, respectively. BPA and PFOA did not induce significant changes in the expression of known nuclear receptors. Overall, each compound produced a unique gene expression signature affecting pathways and GO processes linked to metabolism and inflammation. Twenty-nine genes were significantly altered in expression under all experimental conditions. Six of these genes (HSD11B2, MMP11, ADIPOQ, CEL, DUSP9 and TUB) could be associated with obesity and metabolic syndrome. In conclusion, microarray analysis identified that PBMCs altered their gene expression response in vitro when challenged with EDCs. Our screening approach has identified a number of gene candidates that warrant further study.||Notes:||[Wens, B.; De Boever, P.; Verbeke, M.; Hollanders, K.; Schoeters, G.] Flemish Inst Technol Res VITO, Unit Environm Risk & Hlth, B-2400 Mol, Belgium. [De Boever, P.] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium. [Schoeters, G.] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium.||Keywords:||Endocrine-disrupting chemicals; Peripheral blood mononuclear cells; Gene expression analysis; Microarray; Obesity;Pharmacology & Pharmacy; Toxicology; endocrine-disrupting chemicals; peripheral blood mononuclear cells; gene expression analysis; microarray; obesity||Document URI:||http://hdl.handle.net/1942/15078||ISSN:||0300-483X||e-ISSN:||****-****||DOI:||10.1016/j.tox.2012.10.019||ISI #:||000314856800003||Category:||A1||Type:||Journal Contribution||Validations:||ecoom 2014|
|Appears in Collections:||Research publications|
Show full item record
Files in This Item:
|Wens- cultured human.pdf|
|524 kB||Adobe PDF||View/Open Request a copy|
checked on Sep 3, 2020
WEB OF SCIENCETM
checked on May 22, 2022
checked on May 20, 2022
checked on May 20, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.